Anabolic resistance does not explain sarcopenia in patients with type 2 diabetes mellitus, compared with healthy controls, despite reduced mTOR pathway activity

  • Daniel J. Cuthbertson (Lead / Corresponding author)
  • , John Babraj
  • , Graham Leese
  • , Mario Siervo

    Research output: Contribution to journal › Article › peer-review

    18 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Anabolic resistance does not explain sarcopenia in patients with type 2 diabetes mellitus, compared with healthy controls, despite reduced mTOR pathway activity'. Together they form a unique fingerprint.

    Keyphrases

    Biochemistry, Genetics and Molecular Biology

    Medicine and Dentistry

    Agricultural and Biological Sciences

    Nursing and Health Professions

    Food Science